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Introduction   
   
Multiple myeloma (MM) is a B-cell malignancy characterized by monoclonal 
proliferation of plasma cells in the bone marrow causing multifocal osteolytic lesions 
in the vertebrae, skull, ribs, pelvic bone and the jaw. The term ‘Multiple myeloma’ was 
coined by Von Rustizky in 1873.
1
 It occurs more commonly in older men around 50-80 
years with mean age of 60 years.
2
 Usually, MM manifests systemically as persistent 
bone pain, swelling and fracture, fever, fatigue, recurrent infections, kidney failure, 
hypercalcemia and temporal arteritis. Around 30% of the MM patients develop 
multiple osteolytic jaw lesions and other manifestations like tooth pain and mobility, 
gingival hemorrhage and parasthesia.
3
 But, oral lesions may rarely present as the initial 
sign of MM in around 17% of the cases.
4
 Here, we report a 71 year old male patient 
presenting with pain and solitary swelling in the posterior mandibular. 
 
CASE REPORT: 
 A 71 year old male patient presented with a chief complaint of pain and 
swelling in the left mandibular posterior region since 20 days. Patient had undergone 
extraction of left mandibular molar tooth 1 month back, after which pain and swelling 
did not subside even after taking medication. His personal and family histories were 
non-contributory. On extraoral examination, patient had a swelling of size 4x4 cm with 
diffuse borders, firm consistency (Fig. 1). On intraoral examination, there was a 
swelling extending from 33 to 36 region, causing both buccal and lingual cortical 
expansion and unhealed sockets in relation to 33, 34 and 35.Orthopantamograph 
revealed solitary extensive radiolucent lesion with ill-defined margins perforating the 
lower border of mandible (Fig.2). CT scan of the mandible showed destructive lesion 
(Fig. 3). Routine blood examination revealed reduced RBC count and hemoglobin 
concentration.  
 Microscopic evaluation of incisional biopsy revealed sheets of hyperchromatic 
round cells with few cells showing plasmacytoid features (Fig.4 A, B). An IHC panel for 
round cell tumors was applied and strong positivity for CD 138 (Syndecan-1) was 
obtained. (Fig. 4 C, Table. 1). Hence, diagnosis of solitary plasmacytoma was made and 
further investigations were carried out to check for multiple lesions. On further 
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Abstract      
                         
Multiple myeloma (MM) is a rare hematological malignancy caused by monoclonal 
proliferation of plasma cells in the marrow of various bones. It is more common in men in the 
sixth and seventh decade of life. Patients usually present with bone pain, fatigue, recurrent 
infections, renal failure and nervous system dysfunction. Rarely, oral lesions may be the initial 
sign of multiple myeloma presenting with pain, jaw swelling, tooth mobility, mult iple punched 
out radiolucencies and parasthesia. A case of multiple myeloma occurring in a 71 year old 
male patient who presented with a solitary lesion in the mandible is presented here. This 
paper highlights the importance of knowing oral manifestations of multiple myeloma and 
interdisciplinary approach required for early diagnosis.  
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Fig. 1: Small extra oral swelling in the 
left lower third of the face  
 
Fig. 2: OPG showing ill-defined radiolucency in left mandible molar region 
perforating the lower border.  
 
 
Fig. 3: CT scan showing destructive lesion 
with pathological fracture of left mandible. 
  
 
 
 
Fig. 5: Lateral skull radiograph showing characteristic multiple 
punched out radiolucencies.   
 
 
 
 
Fig. 4: A) Photomicrography shows replacement of bone by an infiltrative highly cellular lesion. (H&E, 4X). B) 
Pleomorphic round cells with few cells showing plasmacytoid differentiation. (H&E, 40X). C) IHC staining shows diffuse 
strong positivity for CD 138 
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Table 1: IHC panel- Round cell tumors 
 
 
Markers Cytokeratin CD 45 S 100 CD 99 CD 138 Desmin 
Results - + - - + - 
 
 
Table. 2: Diagnostic work-up for Multiple Myeloma 
 
 
 
 Skeletal radiograph survey 
 Complete hemogram 
 Urine examination for Bence-Jones proteins and immunoelectrophoresis 
 Serum protein electrophoresis 
 Quantification of immunoglobulins 
 Immunoelectrophoresis 
 Bone marrow examination 
 Biochemical assessment of renal function 
 Calcium status 
 
 
 
round cell tumors was applied and strong positivity for 
CD 138 (Syndecan-1) was obtained. (Fig. 4 C, Table. 1). 
Hence, diagnosis of solitary plasmacytoma was made 
and further investigations were carried out to check for 
multiple lesions. On further evaluation, an x-ray of the 
hand revealed pathological fracture of the humerus, skull 
radiographs revealed multiple punched-out 
radiolucencies (Fig. 5). Considering the presence of 
multiple lesions in the skeleton, serum protein 
electrophoresis was done and it showed increase in ‘M 
protein’ in the beta globulin region. Bone marrow 
examination revealed pleomorphic plasma cells 
confirming the diagnosis of Multiple myeloma.  
The patient was treated with combined 
chemotherapy and radiotherapy. The chemotherapy 
consisted of four cycles of thalidomide and 
corticosteroids. Radiotherapy consisted of 800 cgy to the 
right shoulder. The hand fracture was treated with 
placement of intramedullary nailing with an orthopaedic 
reference. Due to progressive bone pain, patient was 
given palliative treatment with pain killers. The patient 
responded to the treatment with a fifty percent decrease 
in the jaw tumor size after 4 months. But patient failed to 
report back and was lost for follow up.  
 
DISCUSSION: 
 The plasma cell neoplasms of the head and neck 
can be classified into three types: 1) Solitary 
plasmacytoma – affecting single site in bone 2) 
extramedullary plasmacytoma -affecting single site in 
soft tissues and 3) Multiple myeloma – affecting multiple 
sites in the skeleton.
5
Most cases of plasmacytoma 
progresses to multiple myeloma involving multiple sites.  
The plasma cells in multiple myeloma are found 
to have profound genetic instability resulting in a 
complex set of numerical and structural chromosomal 
abnormalities like translocations involving 14q32and the 
immunoglobulin heavy-chain locus.
6 
Bone involvement 
was thought to be due to tumour cell infiltration and 
proliferation. But, it is now believed that osteoclastic 
activating factor, a lymphokine, is responsible for the 
changes.
7,8
 
 The incidence of multiple myeloma is 3:1,00,000 
with a predilection for blacks when compared to whites.
9
 
Clinically, MM usually affects the vertebrae (66%), 
followed by the ribs (44%), skull (41%), and 
pelvis(28%).
6
The incidence of the oral lesions in multiple 
myeloma varies from 2% to 70%.
10
Jaws are affected 
usually at late stage of the disease, but rarely they may 
be the first presentation with an incidence of around 8-
15 %.
11
  Mandible is more commonly affected than 
maxilla and molar region is frequently involved than 
anterior region, as in our case. Oral manifestations of 
MM are jaw swelling, pain, tooth mobility, paresthesia, 
pathological fractures, gingival bleeding and soft tissue 
swelling with amyloid deposition.
3,8
 
Radiographically, MM usually presents as 
multiple radiolucent punched out lesions with distinct 
borders in the jaws. But, it can also occur as solitary 
radiolucent lesion with ill-defined borders as in our case. 
In these cases, further diagnostic work-up should be 
3 
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done to rule out multiple myeloma (Table. 2). Rarely, MM 
can also present as diffuse osteosclerosis.
8 
Bence Jones protein is a monoclonal globulin 
protein found in the blood or urine, with a molecular 
weight of 22-24 kDa. The proteins are immunoglobulin 
light chains (paraproteins) and are produced by 
neoplastic plasma cells. They are found in urine due to 
the kidneys' decreased filtration capabilities due to renal 
failure, sometimes induced by hypercalcemia from the 
calcium released as the bones are destroyed or from the 
light chains themselves. Bence Jones proteins are present 
only in 2/3
rd
 of multiple myeloma cases, hence their 
absence doesn’t rule out the diagnosis.
12
 
A multidisciplinary approach is required to 
confirm the diagnosis when multiple myeloma is 
suspected (Table 2).
13
 Diagnostic criteria for multiple 
myeloma are: 1) increased proliferation of plasma cells  
accompanied by an increase in their production of 
Monoclonal Ig proteins (M-protein)in the serum or urine 
(usually ≥ 30 g/L), 2) at least 10% plasma cells on a 
myelogram, 3) demonstration of monoclonal plasma 
cells on bone marrow biopsy and 4) end organ damage 
like hypercalcaemia, renal insufficiency, anemia, 
osteolytic bone lesions or extramedullary dissemination 
of myeloma tumour cells. Our case was confirmed by the 
increased serum M protein in electrophoresis and by 
bone marrow examination which revealed Grade III MM 
with plasmablastic type of cells with moderate to severe 
degree of pleomorphism and increased mitotic figures. 
Histologically, Multiple myeloma may be graded 
as: I) Low-grade -tumour cells indistinguishable from 
normal plasma cells. II) Intermediate grade -marked 
discrepancy of maturation between nucleus and 
cytoplasm. At least 50% of cells have enlarged nuclei 
with prominent nucleoli. III) High grade -plasmablastic 
type with large nuclei and very prominent centrally 
located nucleoli. The cytoplasm is restricted to a narrow 
rim.
14
Our case belonged to grade III with plasmablastic 
type of cells with moderate to severe degree of 
pleomorphism and increased mitotic figures.  
CD 138 or Syndecan is a useful specific IHC 
marker for plasma cells. The protein encoded by this 
gene is a transmembrane (type I) heparan sulfate 
proteoglycan and is a member of the syndecan 
proteoglycan family. Syndecan-1 protein functions as an 
integral membrane protein and participates in cell 
proliferation, cell migration and cell-matrix interactions 
via its receptor for extracellular matrix proteins.
15
 
Hematological examination with differential and 
total blood counts, biochemical assessment of renal 
function, calcium status, quantification of 
immunoglobulins, immunoelectrophoresis, urinalysis 
which includes immunofixation electrophoresis (IFE) and 
a radiographic skeleton survey should also be obtained 
for treatment planning and prognosis. 
Immunoelectrophoresis or immunofixation is used to 
identify the specific heavy (M, G, A, D, E) and light (κ or 
λ) Ig chain class.
16
 
Differential diagnosis of low grade multiple 
myeloma is plasmablastic lymphomas, where 
plasmacytoid cells can be seen, but they are negative for 
CD 138. In case of high grade multiple myeloma, 
differential diagnosis can be any round cell tumour like 
Ewing’s family of tumours, rhabdomyosarcoma, 
lymphomas, small cell osteosarcoma and metastatic 
small cell tumour of lung. Multiple myeloma in younger 
adults can be a manifestation of HIV and should be 
investigated further. 
 
CONCLUSION: 
 Although rare, oral manifestations can present as 
the initial sign of MM. Hence, clinicians should be aware 
of its manifestation in the oral cavity as a solitary jaw 
lesion. This can lead to an early diagnosis which is 
important for the better treatment and prognosis of 
multiple myeloma patients. 
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